Interaction of human organic anion transporter transporting polypeptides 1B1 and 1B3 with antineoplastic compounds

European Journal of Medicinal Chemistry

Volumn 92, Issue , 2015, Pages 723-731

  Marada, Venkata V V R ^a   Flörl, Saskia ^b   Kühne, Annett ^b   Burckhardt, Gerhard ^a   Hagos, Yohannes ^a,b  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b PortaCellTec Biosciences GmbH   (Germany)

Author keywords

Antineoplastic compounds; Drug transporter interactions; Organic anion transporting polypeptide 1B1; Organic anion transporting polypeptide 1B3; Uptake transporter proteins

Indexed keywords

ANTINEOPLASTIC AGENT; CHLORAMBUCIL; CHOLECYSTOKININ OCTAPEPTIDE; ESTRONE SULFATE; ETOPOSIDE; MITOXANTRONE; PACLITAXEL; SOLUTE CARRIER ORGANIC ANION TRANSPORTER 1B1; SOLUTE CARRIER ORGANIC ANION TRANSPORTER 1B3; VINBLASTINE; VINCRISTINE; ORGANIC ANION TRANSPORTER; PEPTIDE; SLCO1B1 PROTEIN, HUMAN; SLCO1B3 PROTEIN, HUMAN;

ARTICLE; CANCER CHEMOTHERAPY; DRUG PROTEIN BINDING; DRUG UPTAKE; EMBRYO; HEK293 CELL LINE; HUMAN; HUMAN CELL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN TRANSPORT; CELL LINE; CHEMICAL STRUCTURE; CHEMISTRY; METABOLISM; SYNTHESIS;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL LINE; HUMANS; MOLECULAR STRUCTURE; ORGANIC ANION TRANSPORTERS; ORGANIC ANION TRANSPORTERS, SODIUM-INDEPENDENT; PEPTIDES;

EID: 84921646322     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2015.01.011     Document Type: Article

References (36)

1. B. Hagenbuch, B. Stieger, The SLCO (former SLC21) superfamily of transporters, Mol. Asp. Med. 34 (2013) 396-412.
2. B. Hagenbuch, P.J. Meier, The superfamily of organic anion transporting polypeptides, Biochim. Biophys. Acta 1609 (2003) 1-18.
3. T. Abe, M. Kakyo, T. Tokui, R. Nakagomi, T. Nishio, D. Nakai, H. Nomura, M. Unno, M. Suzuki, T. Naitoh, S. Matsuno, H. Yawo, Identification of a novel gene family encoding human liver-specific organic anion transporter LST-1, J. Biol. Chem. 274 (1999) 17159-17163.
4. T. Abe, M. Unno, T. Onogawa, T. Tokui, T.N. Kondo, R. Nakagomi, H. Adachi, K. Fujiwara, M. Okabe, T. Suzuki, K. Nunoki, E. Sato, M. Kakyo, T. Nishio, J. Sugita, N. Asano, M. Tanemoto, M. Seki, F. Date, K. Ono, Y. Kondo, K. Shiiba, M. Suzuki, H. Ohtani, T. Shimosegawa, K. Iinuma, H. Nagura, S. Ito, S. Matsuno, LST-2, a human liver-specific organic anion transporter, determines methotrexate sensitivity in gastrointestinal cancers, Gastroenterology 120 (2001) 1689-1699.
5. E. van de Steeg, E.A. van, E. Wagenaar, K.E. Kenworthy, A.H. Schinkel, Influence of human OATP1B1, OATP1B3, and OATP1A2 on the pharmacokinetics of methotrexate and paclitaxel in humanized transgenic mice, Clin. Cancer Res. 19 (2013) 821-832.
6. N.F. Smith, M.R. Acharya, N. Desai, W.D. Figg, A. Sparreboom, Identification of OATP1B3 as a high-Affinity hepatocellular transporter of paclitaxel, Cancer Biol. Ther. 4 (2005) 815-818.
7. K. Letschert, H. Faulstich, D. Keller, D. Keppler, Molecular characterization and inhibition of amanitin uptake into human hepatocytes, Toxicol. Sci. 91 (2006) 140-149.
8. M. Svoboda, K. Wlcek, B. Taferner, S. Hering, B. Stieger, D. Tong, R. Zeillinger, T. Thalhammer, W. Jager, Expression of organic anion-transporting polypeptides 1B1 and 1B3 in ovarian cancer cells: relevance for paclitaxel transport, Biomed. Pharmacother. 65 (2011) 417-426.
9. T. Nozawa, H. Minami, S. Sugiura, A. Tsuji, I. Tamai, Role of organic anion transporter OATP1B1 (OATP-C) in hepatic uptake of irinotecan and its active metabolite, 7-ethyl-10-hydroxycamptothecin: in vitro evidence and effect of single nucleotide polymorphisms, Drug Metab. Dispos. 33 (2005) 434-439.
10. D. Iusuf, M. Ludwig, A. Elbatsh, E.A. van, E. van de Steeg, E. Wagenaar, V. van d, F. Lin, T.O. van, A.H. Schinkel, OATP1A/1B transporters affect irinotecan and SN-38 pharmacokinetics and carboxylesterase expression in knockout and humanized transgenic mice, Mol. Cancer Ther. 13 (2014) 492-503.
11. J.Y. Han, H.S. Lim, E.S. Shin, Y.K. Yoo, Y.H. Park, J.E. Lee, H.T. Kim, J.S. Lee, Influence of the organic anion-transporting polypeptide 1B1 (OATP1B1) polymorphisms on irinotecan-pharmacokinetics and clinical outcome of patients with advanced non-small cell lung cancer, Lung Cancer 59 (2008) 69-75.
12. P. Taich, A. Ceciliano, E. Buitrago, C. Sampor, A. Fandino, F. Villasante, E. Lucena, L. Romero, G.L. Chantada, P. Schaiquevich, Clinical pharmacokinetics of intra-Arterial melphalan and topotecan combination in patients with retinoblastoma, Ophthalmology 121 (2014) 889-897.
13. P. Jabbour, N. Chalouhi, S. Tjoumakaris, L.F. Gonzalez, A.S. Dumont, R. Chitale, R. Rosenwasser, C.G. Bianciotto, C. Shields, Pearls and pitfalls of intraarterial chemotherapy for retinoblastoma, J. Neurosurg. Pediatr. 10 (2012) 175-181.
14. M. Martino, A. Olivieri, M. Offidani, E. Vigna, T. Moscato, R. Fedele, M. Montanari, G. Console, M. Gentile, G. Messina, G. Irrera, F. Morabito, Addressing the questions of tomorrow: melphalan and new combinations as conditioning regimens before autologous hematopoietic progenitor cell transplantation in multiple myeloma, Expert Opin. Investig. Drugs 22 (2013) 619-634.
15. I. Hus, D. Jawniak, M. Gorska-Kosicka, A. Butrym, J. Dzietczenia, T. Wrobel, M. Grzegorz, E. Lech-Maranda, K. Warzocha, A. Waszczuk-Gajda, W.W. Jedrzejczak, M. Krawczyk-Kulis, S. Kyrcz-Krzemien, L. Poplawska, J. Walewski, A. Dmoszynska, Bendamustine as monotherapy and in combination regimens for the treatment of chronic lymphocytic leukemia and non-Hodgkin lymphoma: a retrospective analysis, Chemotherapy 59 (2014) 280-289.
16. W.U. Knauf, T. Lissichkov, A. Aldaoud, A. Liberati, J. Loscertales, R. Herbrecht, G. Juliusson, G. Postner, L. Gercheva, S. Goranov, M. Becker, H.J. Fricke, F. Huguet, G.I. Del, P. Klein, L. Tremmel, K. Merkle, M. Montillo, Phase III randomized study of bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukemia, J. Clin. Oncol. 27 (2009) 4378-4384.
17. D. Yeo, N. Huynh, J.A. Beutler, C. Christophi, A. Shulkes, G.S. Baldwin, M. Nikfarjam, H. He, Glaucarubinone and gemcitabine synergistically reduce pancreatic cancer growth via down-regulation of P21-Activated kinases, Cancer Lett. 346 (2014) 264-272.
18. E.G. Chiorean, D.D. Von Hoff, Taxanes: impact on pancreatic cancer, Anticancer Drugs 25 (5) (2014) 584-592.
19. T. Deng, L. Zhang, X.J. Liu, J.M. Xu, Y.X. Bai, Y. Wang, Y. Han, Y.H. Li, Y. Ba, Bevacizumab plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) as the second-line therapy for patients with metastatic colorectal cancer, a multicenter study, Med. Oncol. 30 (2013) 752.
20. A. Zaniboni, E. Aitini, S. Barni, D. Ferrari, S. Cascinu, V. Catalano, G. Valmadre, D. Ferrara, E. Veltri, C. Codignola, R. Labianca, FOLFIRI as second-line chemotherapy for advanced pancreatic cancer: a GISCAD multicenter phase II study, Cancer Chemother. Pharmacol. 69 (2012) 1641-1645.
21. Y. Cui, J. Konig, I. Leier, U. Buchholz, D. Keppler, Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6, J. Biol. Chem. 276 (2001) 9626-9630.
22. I. Tamai, T. Nozawa, M. Koshida, J. Nezu, Y. Sai, A. Tsuji, Functional characterization of human organic anion transporting polypeptide B (OATP-B) in comparison with liver-specific OATP-C, Pharm. Res. 18 (2001) 1262-1269.
23. M. Hirano, K. Maeda, Y. Shitara, Y. Sugiyama, Contribution of OATP2 (OATP1B1) and OATP8 (OATP1B3) to the hepatic uptake of pitavastatin in humans, J. Pharmacol. Exp. Ther. 311 (2004) 139-146.
24. M.G. Ismair, B. Stieger, V. Cattori, B. Hagenbuch, M. Fried, P.J. Meier, G.A. Kullak-Ublick, Hepatic uptake of cholecystokinin octapeptide by organic anion-transporting polypeptides OATP4 and OATP8 of rat and human liver, Gastroenterology 121 (2001) 1185-1190.
25. R.S. Obach, F. Lombardo, N.J. Waters, Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds, Drug Metab. Dispos. 36 (2008) 1385-1405.
26. K.M. Giacomini, S.M. Huang, D.J. Tweedie, L.Z. Benet, K.L. Brouwer, X. Chu, A. Dahlin, R. Evers, V. Fischer, K.M. Hillgren, K.A. Hoffmaster, T. Ishikawa, D. Keppler, R.B. Kim, C.A. Lee, M. Niemi, J.W. Polli, Y. Sugiyama, P.W. Swaan, J.A. Ware, S.H. Wright, S.W. Yee, M.J. Zamek-Gliszczynski, L. Zhang, Membrane transporters in drug development, Nat. Rev. Drug Discov. 9 (2010) 215-236.
27. M. Karlgren, G. Ahlin, C.A. Bergstrom, R. Svensson, J. Palm, P. Artursson, In vitro and in silico strategies to identify OATP1B1 inhibitors and predict clinical drug-drug interactions, Pharm. Res. 29 (2012) 411-426.
28. M. Karlgren, A. Vildhede, U. Norinder, J.R. Wisniewski, E. Kimoto, Y. Lai, U. Haglund, P. Artursson, Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drugdrug interactions, J. Med. Chem. 55 (2012) 4740-4763.
29. E. van de Steeg, C.M. van der Kruijssen, E. Wagenaar, J.E. Burggraaff, E. Mesman, K.E. Kenworthy, A.H. Schinkel, Methotrexate pharmacokinetics in transgenic mice with liver-specific expression of human organic aniontransporting polypeptide 1B1 (SLCO1B1), Drug Metab. Dispos. 37 (2009) 277-281.
30. S. Izumi, Y. Nozaki, T. Komori, K. Maeda, O. Takenaka, K. Kusano, T. Yoshimura, H. Kusuhara, Y. Sugiyama, Substrate-dependent inhibition of organic anion transporting polypeptide 1B1: comparative analysis with prototypical probe substrates estradiol-17beta-glucuronide, estrone-3-sulfate, and sulfobromophthalein, Drug Metab. Dispos. 41 (2013) 1859-1866.
31. B.T. De, G.J. van Westen, A.P. Ijzerman, B. Stieger, W.P. de, P.F. Augustijns, P.P. Annaert, Structure-based identification of OATP1B1/3 inhibitors, Mol. Pharmacol. 83 (2013) 1257-1267.
32. X. Wang, A.W. Wolkoff, M.E. Morris, Flavonoids as a novel class of human organic anion-transporting polypeptide OATP1B1 (OATP-C) modulators, Drug Metab. Dispos. 33 (2005) 1666-1672.
33. C. Gui, Y. Miao, L. Thompson, B. Wahlgren, M. Mock, B. Stieger, B. Hagenbuch, Effect of pregnane X receptor ligands on transport mediated by human OATP1B1 and OATP1B3, Eur. J. Pharmacol. 584 (2008) 57-65.
34. J. Noe, R. Portmann, M.E. Brun, C. Funk, Substrate-dependent drug-drug interactions between gemfibrozil, fluvastatin and other organic aniontransporting peptide (OATP) substrates on OATP1B1, OATP2B1, and OATP1B3, Drug Metab. Dispos. 35 (2007) 1308-1314.
35. C. Gui, B. Hagenbuch, Role of transmembrane domain 10 for the function of organic anion transporting polypeptide 1B1, Protein Sci. 18 (2009) 2298-2306.
36. U.I. Schwarz, Zu Meyer, H.E. Schwabedissen, R.G. Tirona, A. Suzuki, B.F. Leake, Y. Mokrab, K. Mizuguchi, R.H. Ho, R.B. Kim, Identification of novel functional organic anion-transporting polypeptide 1B3 polymorphisms and assessment of substrate specificity, Pharmacogenet Genomics 21 (2011) 103-114.